• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘内注射U1衔接子寡核苷酸在小鼠体内的组织分布药代动力学

Tissue distribution pharmacokinetics of intrathecal U1 adaptor oligonucleotide in mice.

作者信息

Satti Medha, Prasad Kavita, Patel Yash, Poulathas Demi, Walker Lawrence, Paghdal Esha, Gunderson Samuel, Yu Lei

机构信息

Department of Genetics, Rutgers University, Piscataway, NJ, 08854, USA.

Center of Alcohol & Substance Use Studies, Rutgers University, Piscataway, NJ, 08854, USA.

出版信息

Curr Res Pharmacol Drug Discov. 2025 Apr 17;8:100220. doi: 10.1016/j.crphar.2025.100220. eCollection 2025.

DOI:10.1016/j.crphar.2025.100220
PMID:40322586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049946/
Abstract

U1 Adaptor is a novel gene-silencing technology, offering an innovative approach to target genes in the CNS for the treatment of diseases. Intrathecal delivery is a medically viable route of administration of CNS-bound nucleic acid drugs; therefore, it is important to investigate U1 Adaptor distribution after intrathecal drug delivery. We investigated the distribution patterns of U1 Adaptor upon intrathecal bolus administration in mice. It readily distributes to CNS tissues, including the lumbar and the cervical spinal cord, and the cerebellum. Over time, the U1 Adaptor also accumulates in the periphery, both in the liver and the kidneys, while plasma levels are undetectable. Our findings provide useful information for future in-depth pharmacokinetic modeling of U1 Adaptor distribution upon intrathecal administration.

摘要

U1衔接子是一种新型基因沉默技术,为中枢神经系统(CNS)中的靶基因治疗疾病提供了一种创新方法。鞘内给药是中枢神经系统靶向核酸药物的一种医学可行给药途径;因此,研究鞘内给药后U1衔接子的分布很重要。我们研究了小鼠鞘内推注给药后U1衔接子的分布模式。它很容易分布到中枢神经系统组织,包括腰段和颈段脊髓以及小脑。随着时间的推移,U1衔接子也在外周组织中积累,包括肝脏和肾脏,而血浆中检测不到其水平。我们的研究结果为未来深入开展鞘内给药后U1衔接子分布的药代动力学建模提供了有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/091c/12049946/95ce7bda8bd5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/091c/12049946/32e16a8fd4f5/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/091c/12049946/95ce7bda8bd5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/091c/12049946/32e16a8fd4f5/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/091c/12049946/95ce7bda8bd5/gr1.jpg

相似文献

1
Tissue distribution pharmacokinetics of intrathecal U1 adaptor oligonucleotide in mice.鞘内注射U1衔接子寡核苷酸在小鼠体内的组织分布药代动力学
Curr Res Pharmacol Drug Discov. 2025 Apr 17;8:100220. doi: 10.1016/j.crphar.2025.100220. eCollection 2025.
2
U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo.靶向 BCL2 和 GRM1 的 U1 衔接寡核苷酸在体内抑制人黑色素瘤异种移植物的生长。
Mol Ther Nucleic Acids. 2013 May 14;2(5):e92. doi: 10.1038/mtna.2013.24.
3
U1 Adaptors Suppress the Oncogenic Axis in Human Pancreatic Cancer Xenografts.U1 衔接子抑制人胰腺癌细胞异种移植瘤中的致癌轴。
Mol Cancer Ther. 2017 Aug;16(8):1445-1455. doi: 10.1158/1535-7163.MCT-16-0867. Epub 2017 Apr 4.
4
U1 adaptors for the therapeutic knockdown of the oncogene pim-1 kinase in glioblastoma.用于胶质母细胞瘤中致癌基因 pim-1 激酶治疗性敲低的 U1 衔接子。
Nucleic Acid Ther. 2013 Aug;23(4):264-72. doi: 10.1089/nat.2012.0407. Epub 2013 Jun 1.
5
A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.一种基于生理学的药代动力学模型,用于描述鞘内给予反义寡核苷酸后的分布。
J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):639-654. doi: 10.1007/s10928-021-09761-0. Epub 2021 May 15.
6
U1 adaptors result in reduction of multiple pre-mRNA species principally by sequestering U1snRNP.U1 衔接子主要通过隔离 U1snRNP 导致多种前体 mRNA 种类减少。
Nucleic Acids Res. 2011 May;39(10):e71. doi: 10.1093/nar/gkr150. Epub 2011 Mar 16.
7
Gene silencing by synthetic U1 adaptors.通过合成U1衔接子实现基因沉默。
Nat Biotechnol. 2009 Mar;27(3):257-63. doi: 10.1038/nbt.1525. Epub 2009 Feb 15.
8
Intrathecal administration of Anti-Nogo-A antibody in macaque monkeys: Pharmacokinetics, tissue penetration and target interaction.猕猴鞘内注射抗Nogo-A抗体:药代动力学、组织穿透及靶点相互作用
Neurotherapeutics. 2025 Mar;22(2):e00484. doi: 10.1016/j.neurot.2024.e00484. Epub 2024 Nov 20.
9
Biodistribution of Idursulfase Formulated for Intrathecal Use (Idursulfase-IT) in Cynomolgus Monkeys after Intrathecal Lumbar Administration.鞘内注射用艾度硫酸酯酶(鞘内用艾度硫酸酯酶)经腰椎鞘内给药后在食蟹猴体内的生物分布。
PLoS One. 2016 Oct 20;11(10):e0164765. doi: 10.1371/journal.pone.0164765. eCollection 2016.
10
Mechanistic Modeling of Intrathecal Chemotherapy Pharmacokinetics in the Human Central Nervous System.鞘内化疗药代动力学的人体中枢神经系统的机制建模。
Clin Cancer Res. 2024 Apr 1;30(7):1397-1408. doi: 10.1158/1078-0432.CCR-23-3062.

本文引用的文献

1
Determination of spinal tracer dispersion after intrathecal injection in a deformable CNS model.在可变形中枢神经系统模型中鞘内注射后脊髓示踪剂扩散的测定
Front Physiol. 2023 Sep 25;14:1244016. doi: 10.3389/fphys.2023.1244016. eCollection 2023.
2
Pre-clinical delivery of gene therapy products to the cerebrospinal fluid: challenges and considerations for clinical translation.基因治疗产品向脑脊液的临床前递送:临床转化的挑战与考量
Front Mol Neurosci. 2023 Aug 17;16:1248271. doi: 10.3389/fnmol.2023.1248271. eCollection 2023.
3
Nucleic acid-based therapeutics for the treatment of central nervous system disorders.
用于治疗中枢神经系统疾病的核酸类疗法。
Front Genet. 2023 Aug 16;14:1250276. doi: 10.3389/fgene.2023.1250276. eCollection 2023.
4
A mechanistic pharmacokinetic model for intrathecal administration of antisense oligonucleotides.鞘内注射反义寡核苷酸的机制性药代动力学模型。
Front Physiol. 2023 Jun 2;14:1130925. doi: 10.3389/fphys.2023.1130925. eCollection 2023.
5
Epidural and Intrathecal Drug Delivery in Rats and Mice for Experimental Research: Fundamental Concepts, Techniques, Precaution, and Application.用于实验研究的大鼠和小鼠硬膜外及鞘内给药:基本概念、技术、注意事项及应用
Biomedicines. 2023 May 10;11(5):1413. doi: 10.3390/biomedicines11051413.
6
Chemistry, structure and function of approved oligonucleotide therapeutics.已获批的寡核苷酸治疗药物的化学、结构和功能。
Nucleic Acids Res. 2023 Apr 11;51(6):2529-2573. doi: 10.1093/nar/gkad067.
7
Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives.寡核苷酸疗法在中枢神经系统中的生物分布与递送:进展、挑战及未来展望
Biopharm Drug Dispos. 2023 Feb;44(1):26-47. doi: 10.1002/bdd.2338. Epub 2022 Nov 16.
8
A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.一种基于生理学的药代动力学模型,用于描述鞘内给予反义寡核苷酸后的分布。
J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):639-654. doi: 10.1007/s10928-021-09761-0. Epub 2021 May 15.
9
Intrathecal drug delivery in the era of nanomedicine.纳⽶医学时代的鞘内药物输送。
Adv Drug Deliv Rev. 2020;165-166:77-95. doi: 10.1016/j.addr.2020.02.006. Epub 2020 Mar 3.
10
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging.鞘内反义寡核苷酸的脑药理学通过多模态成像揭示。
JCI Insight. 2019 Oct 17;4(20):129240. doi: 10.1172/jci.insight.129240.